AxoGen (AXGN) Competitors $17.19 +1.55 (+9.91%) (As of 12/23/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AXGN vs. IRTC, WRBY, LIVN, ENOV, TNDM, CNMD, TMDX, SLNO, INMD, and RXSTShould you be buying AxoGen stock or one of its competitors? The main competitors of AxoGen include iRhythm Technologies (IRTC), Warby Parker (WRBY), LivaNova (LIVN), Enovis (ENOV), Tandem Diabetes Care (TNDM), CONMED (CNMD), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), InMode (INMD), and RxSight (RXST). These companies are all part of the "medical equipment" industry. AxoGen vs. iRhythm Technologies Warby Parker LivaNova Enovis Tandem Diabetes Care CONMED TransMedics Group Soleno Therapeutics InMode RxSight iRhythm Technologies (NASDAQ:IRTC) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability. Which has stronger valuation & earnings, IRTC or AXGN? AxoGen has lower revenue, but higher earnings than iRhythm Technologies. AxoGen is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$560.03M4.95-$123.41M-$4.86-18.24AxoGen$180.86M4.18-$21.72M-$0.32-53.72 Do analysts rate IRTC or AXGN? iRhythm Technologies presently has a consensus target price of $109.27, suggesting a potential upside of 23.25%. AxoGen has a consensus target price of $15.00, suggesting a potential downside of 12.74%. Given iRhythm Technologies' higher probable upside, equities research analysts plainly believe iRhythm Technologies is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82AxoGen 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is IRTC or AXGN more profitable? AxoGen has a net margin of -7.91% compared to iRhythm Technologies' net margin of -26.90%. AxoGen's return on equity of -14.91% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-26.90% -120.86% -17.96% AxoGen -7.91%-14.91%-7.49% Do insiders and institutionals believe in IRTC or AXGN? 80.3% of AxoGen shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by insiders. Comparatively, 7.0% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer IRTC or AXGN? In the previous week, iRhythm Technologies had 4 more articles in the media than AxoGen. MarketBeat recorded 6 mentions for iRhythm Technologies and 2 mentions for AxoGen. AxoGen's average media sentiment score of 0.95 beat iRhythm Technologies' score of 0.76 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer IRTC or AXGN? AxoGen received 48 more outperform votes than iRhythm Technologies when rated by MarketBeat users. Likewise, 72.71% of users gave AxoGen an outperform vote while only 66.18% of users gave iRhythm Technologies an outperform vote. CompanyUnderperformOutperformiRhythm TechnologiesOutperform Votes40566.18% Underperform Votes20733.82% AxoGenOutperform Votes45372.71% Underperform Votes17027.29% Which has more risk and volatility, IRTC or AXGN? iRhythm Technologies has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. SummaryAxoGen beats iRhythm Technologies on 11 of the 18 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AXGN vs. The Competition Export to ExcelMetricAxoGenElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$756.50M$3.14B$5.20B$9.14BDividend YieldN/A1.77%5.12%4.29%P/E Ratio-53.7217.1587.0717.11Price / Sales4.1852.731,159.67122.74Price / CashN/A39.9343.2337.85Price / Book7.743.794.804.78Net Income-$21.72M$89.83M$120.46M$225.43M7 Day Performance16.62%0.85%-0.91%-0.82%1 Month Performance28.86%-0.91%14.91%1.02%1 Year Performance145.57%0.96%29.59%15.72% AxoGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AXGNAxoGen1.0651 of 5 stars$17.19+9.9%$15.00-12.7%+145.6%$756.50M$180.86M-53.72426Gap UpIRTCiRhythm Technologies2.921 of 5 stars$88.54-2.0%$109.27+23.4%-17.2%$2.77B$560.03M-18.222,000WRBYWarby Parker1.5973 of 5 stars$25.54+1.4%$20.73-18.8%+85.4%$2.60B$742.53M-94.593,491LIVNLivaNova3.4688 of 5 stars$46.89-1.5%$69.17+47.5%-9.3%$2.55B$1.24B111.642,900ENOVEnovis3.0052 of 5 stars$43.09-0.1%$67.00+55.5%-24.3%$2.41B$2.00B-19.686,550Positive NewsTNDMTandem Diabetes Care4.7123 of 5 stars$36.19+0.8%$53.81+48.7%+24.1%$2.38B$854.35M-18.752,400Positive NewsCNMDCONMED4.6302 of 5 stars$69.10+0.7%$79.80+15.5%-38.7%$2.13B$1.29B16.414,000Positive NewsTMDXTransMedics Group4.0599 of 5 stars$62.78+1.8%$122.70+95.4%-20.3%$2.11B$401.09M66.79210Gap UpSLNOSoleno Therapeutics4.4801 of 5 stars$44.69-1.1%$74.83+67.4%+18.6%$1.93BN/A-13.4630INMDInMode3.5867 of 5 stars$17.14+0.4%$22.60+31.9%-25.4%$1.44B$423.75M9.26480Positive NewsRXSTRxSight2.8034 of 5 stars$34.67+3.0%$59.00+70.2%-12.7%$1.40B$128.29M-41.77220 Related Companies and Tools Related Companies IRTC Alternatives WRBY Alternatives LIVN Alternatives ENOV Alternatives TNDM Alternatives CNMD Alternatives TMDX Alternatives SLNO Alternatives INMD Alternatives RXST Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AXGN) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AXGN Stock Alerts